Mastodawn

This brief highlights a novel mechanism linking cellular energy production to cognitive function, a topic with meaningful implications for clinicians observing memory changes in neurodegenerative conditions. The finding that temporarily boosting mitochondrial activity can restore memory performance in animal models underscores the importance of neuronal energy dynamics as a potential domain for assessment and intervention awareness among mental health practitioners, social workers, and therapists working with patients at risk for cognitive decline.

Article Title: Scientists reversed memory loss by recharging the brain’s tiny engines

Link to Science Daily Mind-Brain News: https://nolinkpreview.com/www.sciencedaily.com/releases/2026/05/260515234803.htm

#memory #neurodegeneration #mitochondria #cognition #Alzheimers #neuroscience #brainhealth #therapeutics #neuroplasticity #mentalhealth

Scientific Frontline Apr 28

Exosomes containing signaling molecules derived from wild Scandinavian flatworms can significantly accelerate tissue repair and wound healing in human skin models.
#ChemicalBiology #RegenerativeMedicine #MolecularBiology #Therapeutics #sflorg
https://www.sflorg.com/2026/04/bio04282601.html

Wild flatworms heal wounds

The study suggests that signaling molecules from flatworms can accelerate the human body’s own healing processes

Psychotherapy Commission ACPE Mar 17

Reason this briefing matters for mental health professionals: It highlights a mechanistic link between immune activation in the brain and amyloid clearance, which may inform understanding of neuroinflammatory processes involved in cognitive decline and dementia. Awareness of how biological targets influence neural health can illuminate potential avenues for interdisciplinary collaboration and referral strategies when addressing memory-related concerns in clients.

Article Title: Scientists finally reveal how this Alzheimer’s drug really works

Link to Science Daily Mind-Brain News: https://www dot sciencedaily dot com/releases/2026/03/260317064457 dot htm

#alzheimers #immuneactivation #microglia #neurodegeneration #therapeutics

Copy and paste broken link above into your browser and replace "dot" with "." for link to work.

We have to do it this way to avoid display of copyrighted images.

Das Feb 16

Single Dose of DMT Rapidly Reduces Symptoms of Major Depression

Small Phase IIa study [34 subjects] but some interesting points
"intravenous DMT has a half-life of around five minute"
and
"A single dose of DMT with psychotherapeutic support produced a rapid, significant reduction in depressive symptoms, sustained up to three months,"

https://www.sciencealert.com/single-dose-of-dmt-rapidly-reduces-symptoms-of-major-depression

Primary article: https://www.nature.com/articles/s41591-025-04154-z

#Science #Depression #Therapeutics

Single Dose of DMT Rapidly Reduces Symptoms of Major Depression

In an early clinical trial, a single dose of a short-acting psychedelic drug led to rapid improvement in people with major depressive disorder.

ScienceAlert

Show thread

Chuck Darwin Jan 17

When the immune system detects a protein from a pathogen,
it’s supposed to dispatch killer T cells to eliminate the invader.

Some cancers can interfere with this process by hijacking the checkpoint proteins that keep our immune system from revving out of control
and using them to turn T cells off.

Starting in the mid-1990s, several research teams found success by treating mice with #checkpoint #inhibitors,
-- then a new class of drugs designed to keep tumor cells from concealing their identity and signaling, effectively, “nothing to see here.”

Thirty years on, checkpoint inhibitors have become a transformative tool in cancer treatment, especially for melanoma.

The research that went into developing checkpoint inhibitors showed conclusively that immune cells detect cancer much in the same way they identify other pathogens:

through differences in protein structure determined by DNA
—a crucial insight.

But as revolutionary as checkpoint inhibitors have been for immunotherapy, they don’t work for everyone
—far from it.

Some 80 percent of patients do not respond to this class of drugs.

Researchers are still trying to understand all the mechanisms that play a role in determining who does respond,
but one key factor is whether the immune system is able to recognize tumor cells on the basis of their mutations.

This is where mRNA vaccines come in.

#Jason #Luke, a melanoma researcher who now serves as chief medical officer of mRNA-medicine start-up #Strand #Therapeutics,
helped to design several ongoing clinical trials of mRNA vaccines for cancer.

He explains that both checkpoint inhibitors and mRNA vaccines build on our deep evolutionary adaptation for fighting pathogens
by identifying the proteins they shed in our bodies.

But checkpoint inhibitors are effective only if the patient’s immune system recognizes the cancer as a threat.

In contrast, mRNA vaccines have the potential to work even in patients whose cancers haven’t spurred much immune response.

The trick, Luke says, is using computational tools to decipher which of a given tumor’s mutations are most likely to be found by the immune system.

#MichaelMemoli
#WilliamColey #immunotherapy #stroma #MHC